Along with my team, we are challenging the paradigm in the treatment of CLL, ALL, AML and multiple myeloma and helping bring to Market solutions for key unmet needs

As the lead for Hematology and Oncology, specifically lung and breast cancer, for my current organisation; I am the voice of the region to the global organization, ensuring that, while the region contributes to the overall science and organisational objectives; we fulfil the aspirations of the Asia Pacific local affiliates, medical and KOL community.

Head of Medical Affairs is accountable for Governance and Compliance; LoC Clinical Trials; Team Management; Medical Marketing; Execution of Medical Action Plan; Risk Mitigation; Product Recall and Management; Brand Development; Life Cycle Management; Named Patient Programs and Single Patient Compassionate Use KOL Development & Budget Management.

Therapy Area Specialist-Asia Pacific; Oncology

Graduated as a Senior Resident after 5 years of training in Medical Oncology and Hemato-Oncology; unregistered.Responsible for OPD and own ward of 27 beds.9 months of Pediatric Oncology.Trained in Flow Cytometry; FISH; PCR; RT/RQ PCR; Cell Line.Conducted Numerous Trials in Oncology as associate/assistant to PI.Participation in Journal clubs; held 4 times a week.Cell line study on p53 characterisation in H&N Cancer as secondary Malignancy after Ch. Myeloid Leukemia ongoing and being considered.